Literature DB >> 21979433

The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells.

Clara Cavelier1, Pascale M Ohnsorg, Lucia Rohrer, Arnold von Eckardstein.   

Abstract

OBJECTIVE: Both HDLs and their major protein constituent apolipoprotein A-I (apoA-I) are transported through aortic endothelial cells. The knock-down of the ATP-binding cassette transporters A1 (ABCA1), G1 (ABCG1), and of the scavenger receptor-BI (SR-BI) diminishes but does not completely block the transport of apoA-I or HDL, so that other receptors appear to be involved. The ectopic β-chain of F(0)F(1) ATPase has been previously characterized as an apoA-I receptor, triggering HDL internalization in hepatocytes. METHODS AND
RESULTS: The ectopic presence of the β-chain of F(0)F(1) ATPase on the surface of endothelial cells was confirmed by cell surface biotinylation. RNA-interference and the F(0)F(1) ATPase inhibitory peptide IF(1) reduced cell binding of apoA-I but not HDL, as well as association and transendothelial transport of both apoA-I and HDL. Furthermore, apoA-I stimulated F(0)F(1) ATPase catalyzed ATP hydrolysis. The generated ADP as well as apoA-I stimulated the binding, cell association, and internalization of HDL. Both in the presence and absence of ADP inhibition of the purinergic receptor P2Y(12) but not P2Y(1) decreased the cell association of apoA-I and HDL. Coinhibition of β-ATPase and ABCA1 had no additive effects on the cell association and transport of apoA-I. Reduced cell association of HDL by β-ATPase inhibition was not further decreased by additional knock-down of ABCG1 or SR-BI.
CONCLUSIONS: Binding of apoA-I to ectopic F(0)F(1) ATPase triggers the generation of ADP, which via activation of the purinergic receptor P2Y(12) stimulates the uptake and transport of HDL and initially lipid-free apoA-I by endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979433     DOI: 10.1161/ATVBAHA.111.238063

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

1.  LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans.

Authors:  C Charles Michel; M Nazeem Nanjee; Waldemar L Olszewski; Norman E Miller
Journal:  J Lipid Res       Date:  2014-11-14       Impact factor: 5.922

Review 2.  Lymphatic transport of high-density lipoproteins and chylomicrons.

Authors:  Gwendalyn J Randolph; Norman E Miller
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 3.  Assessing the barriers to image-guided drug delivery.

Authors:  Gregory M Lanza; Chrit Moonen; James R Baker; Esther Chang; Zheng Cheng; Piotr Grodzinski; Katherine Ferrara; Kullervo Hynynen; Gary Kelloff; Yong-Eun Koo Lee; Anil K Patri; David Sept; Jan E Schnitzer; Bradford J Wood; Miqin Zhang; Gang Zheng; Keyvan Farahani
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-31

Review 4.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

Review 5.  Mechanisms of ATP release and signalling in the blood vessel wall.

Authors:  Alexander W Lohman; Marie Billaud; Brant E Isakson
Journal:  Cardiovasc Res       Date:  2012-06-07       Impact factor: 10.787

6.  V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Kailash Gulshan; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

Review 7.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 8.  Atherosclerosis and transit of HDL through the lymphatic vasculature.

Authors:  Catherine Martel; Gwendalyn J Randolph
Journal:  Curr Atheroscler Rep       Date:  2013-09       Impact factor: 5.113

9.  Circulating HDL levels control hypothalamic astrogliosis via apoA-I.

Authors:  Anna Götz; Maarit Lehti; Elizabeth Donelan; Cynthia Striese; Sebastian Cucuruz; Stephan Sachs; Chun-Xia Yi; Stephen C Woods; Samuel D Wright; Timo D Müller; Matthias H Tschöp; Yuanqing Gao; Susanna M Hofmann
Journal:  J Lipid Res       Date:  2018-07-10       Impact factor: 5.922

10.  High-density lipoprotein endocytosis in endothelial cells.

Authors:  Stefanie Fruhwürth; Margit Pavelka; Robert Bittman; Werner J Kovacs; Katharina M Walter; Clemens Röhrl; Herbert Stangl
Journal:  World J Biol Chem       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.